Xinghua Cheng

1.8k total citations
48 papers, 1.2k citations indexed

About

Xinghua Cheng is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Xinghua Cheng has authored 48 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Xinghua Cheng's work include Lung Cancer Diagnosis and Treatment (19 papers), Lung Cancer Treatments and Mutations (11 papers) and Advanced Radiotherapy Techniques (5 papers). Xinghua Cheng is often cited by papers focused on Lung Cancer Diagnosis and Treatment (19 papers), Lung Cancer Treatments and Mutations (11 papers) and Advanced Radiotherapy Techniques (5 papers). Xinghua Cheng collaborates with scholars based in China, United Kingdom and United States. Xinghua Cheng's co-authors include Richard Siow, Giovanni E. Mann, Sarah J. Chapple, Haiquan Chen, Ching-Hsin Ku, Qingquan Luo, Yunhai Yang, Yihua Sun, David Sugden and Ling Gao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Diabetes.

In The Last Decade

Xinghua Cheng

41 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinghua Cheng China 17 521 372 192 172 112 48 1.2k
Yuki Izawa‐Ishizawa Japan 23 421 0.8× 223 0.6× 178 0.9× 190 1.1× 123 1.1× 76 1.5k
Xuansheng Ding China 23 727 1.4× 229 0.6× 350 1.8× 157 0.9× 145 1.3× 89 1.6k
Dae‐Woon Eom South Korea 20 362 0.7× 241 0.6× 129 0.7× 254 1.5× 204 1.8× 70 1.1k
Yosuke Kayama Japan 16 830 1.6× 294 0.8× 213 1.1× 108 0.6× 301 2.7× 29 2.1k
Christudas Morais Australia 19 483 0.9× 309 0.8× 205 1.1× 145 0.8× 91 0.8× 60 1.0k
Qing Lü United States 24 599 1.1× 361 1.0× 118 0.6× 90 0.5× 106 0.9× 44 1.3k
Peiqing Liu China 15 773 1.5× 325 0.9× 411 2.1× 166 1.0× 123 1.1× 35 1.6k
Joep H.M. van Esch Netherlands 22 623 1.2× 301 0.8× 86 0.4× 188 1.1× 135 1.2× 26 1.8k
Chunlai Zeng China 20 413 0.8× 166 0.4× 106 0.6× 83 0.5× 134 1.2× 48 1.1k
Chao Zheng China 21 454 0.9× 117 0.3× 130 0.7× 151 0.9× 221 2.0× 80 1.3k

Countries citing papers authored by Xinghua Cheng

Since Specialization
Citations

This map shows the geographic impact of Xinghua Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinghua Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinghua Cheng more than expected).

Fields of papers citing papers by Xinghua Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinghua Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinghua Cheng. The network helps show where Xinghua Cheng may publish in the future.

Co-authorship network of co-authors of Xinghua Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Xinghua Cheng. A scholar is included among the top collaborators of Xinghua Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinghua Cheng. Xinghua Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Shuai, et al.. (2025). ASH2L‐K312‐Lac Stimulates Angiogenesis in Tumors to Expedite the Malignant Progression of Hepatocellular Carcinoma. Advanced Science. 12(40). e09477–e09477. 2 indexed citations
2.
Wang, Xiang, Wen Cao, Xinghua Cheng, et al.. (2025). mPEG-NH2/2-FPBA/TubA exerts anti-hepatocellular carcinoma activity by targeting ABCF1-K430la through the KDM3A-H3K9me2-HIF1A axis. Colloids and Surfaces B Biointerfaces. 255. 114941–114941.
3.
Cheng, Xinghua, Xin Ge, Chi Zhang, et al.. (2025). Tryptophan Suppresses FTH1 ‐Driven Ferritinophagy, a Key Correlate of Prognosis in Hepatocellular Carcinoma. Cell Proliferation. 59(1). e70074–e70074.
4.
Li, Yin, Liliang Xia, Hui Wang, et al.. (2025). Single-cell spatial proteomics of non-relapse small cell lung cancer identifies tumor microenvironment determinants of survival. Cell Biology and Toxicology. 41(1). 106–106.
5.
6.
Zheng, Xiaoxiao, Fangqian Chen, Shufen Zhang, et al.. (2024). RBM15 facilitates osimertinib resistance of lung adenocarcinoma through m6A-dependent epigenetic silencing of SPOCK1. Oncogene. 44(5). 307–321. 6 indexed citations
7.
He, Lin, Xinghua Cheng, Yun Gu, et al.. (2024). Fruquintinib Combined With PD-1 Inhibitors for the Treatment of the Patients With Microsatellite Stability Metastatic Colorectal Cancer: Real-World Data. Clinical Oncology. 38. 103700–103700. 1 indexed citations
8.
Peng, Mingzheng, et al.. (2021). Augmented reality-assisted localization of solitary pulmonary nodules for precise sublobar lung resection: a preliminary study using an animal model. Translational Lung Cancer Research. 10(11). 4174–4184. 7 indexed citations
9.
Zhao, Xu, Caiyou Hu, Shanshan Chen, et al.. (2019). Apatinib enhances chemosensitivity of gastric cancer to paclitaxel and 5-fluorouracil. SHILAP Revista de lepidopterología. 4 indexed citations
10.
Cheng, Xinghua, Jin Qiu, Sainan Wang, et al.. (2019). Comprehensive circular RNA profiling identifies CircFAM120A as a new biomarker of hypoxic lung adenocarcinoma. Annals of Translational Medicine. 7(18). 442–442. 30 indexed citations
11.
Li, Jing, Wenjie You, Difan Zheng, et al.. (2018). A comprehensive evaluation of clinicopathologic characteristics, molecular features and prognosis in lung adenocarcinoma with solid component. Journal of Cancer Research and Clinical Oncology. 144(4). 725–734. 18 indexed citations
12.
Cheng, Xinghua, et al.. (2018). Three-arm robot-assisted thoracoscopic surgery for locally advanced N2 non-small cell lung cancer. Journal of Thoracic Disease. 10(12). 7009–7013. 3 indexed citations
13.
Cheng, Xinghua, Mark W. Onaitis, Thomas A. D’Amico, & Haiquan Chen. (2017). Minimally Invasive Thoracic Surgery 3.0. Annals of Surgery. 267(1). 37–38. 37 indexed citations
14.
Zheng, Difan, Haiquan Chen, Rui Wang, et al.. (2016). The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populations. OncoTargets and Therapy. 833–833. 39 indexed citations
15.
Luo, Jizhuang, Rui Wang, Baohui Han, et al.. (2016). Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma. Oncotarget. 8(4). 7050–7058. 16 indexed citations
16.
Zheng, Difan, Rui Wang, Yang Zhang, et al.. (2015). Prevalence and clinicopathological characteristics of ALK fusion subtypes in lung adenocarcinomas from Chinese populations. Journal of Cancer Research and Clinical Oncology. 142(4). 833–843. 14 indexed citations
17.
Huang, Qingyuan, Jinhui Li, Yihua Sun, et al.. (2015). Efficacy of EGFR Tyrosine Kinase Inhibitors in the Adjuvant Treatment for Operable Non-small Cell Lung Cancer by a Meta-Analysis. CHEST Journal. 149(6). 1384–1392. 37 indexed citations
18.
19.
Siow, Richard, et al.. (2010). Induction of HO-1 and redox signaling in endothelial cells by advanced glycation end products: A role for Nrf2 in vascular protection in diabetes. Nutrition Metabolism and Cardiovascular Diseases. 21(4). 277–85. 97 indexed citations
20.
Cheng, Xinghua, et al.. (2009). The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC). European Journal of Surgical Oncology. 35(10). 1105–1108. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuki Izawa‐Ishizawa Breakdown of academic impact, for papers by Xuansheng Ding Breakdown of academic impact, for papers by Dae‐Woon Eom Breakdown of academic impact, for papers by Yosuke Kayama Breakdown of academic impact, for papers by Christudas Morais Breakdown of academic impact, for papers by Qing Lü Breakdown of academic impact, for papers by Peiqing Liu Breakdown of academic impact, for papers by Joep H.M. van Esch Breakdown of academic impact, for papers by Chunlai Zeng Breakdown of academic impact, for papers by Chao Zheng
Rankless by CCL
2026